House Bill Would Expand Rx Market, But Negatives Draw PhRMA's Protest
Executive Summary
The House health care reform bill contains a number of provisions that would greatly expand the market for pharmaceuticals, but the bill seeks a number of financial concessions from pharmaceutical manufacturers, prompting a statement of protest from the industry association
You may also be interested in...
DTC Drug Ad Tax Deductibility Proposal Supported By Finance Committee Member
Key Finance Committee member Nelson will offer amendment that would deny tax deduction for DTC drug ads.
Part D Mandated Rebates: CBO Weighs In On Likely Premium Increases
Medicare Part D premiums would be 5 percent higher in 2011 - and about 20 percent higher in 2019 - than they would be under current law if Part D revisions included in the House Tri-committee health reform bill are enacted, according to the Congressional Budget Office
Part D Mandated Rebates: CBO Weighs In On Likely Premium Increases
Medicare Part D premiums would be 5 percent higher in 2011 - and about 20 percent higher in 2019 - than they would be under current law if Part D revisions included in the House Tri-committee health reform bill are enacted, according to the Congressional Budget Office